The CALLY Index Is Associated with Overall Survival in Patients with De Novo Metastatic Gastric Adenocarcinoma

Fahri Akgül, Süleyman Can, İvo Gökmen, Gizem Bakır Kahveci, İsmail Bayrakçı, Dicle Yurdatap Koç, Ece Demirdelen, Veli Çakıcı, Bülent Erdoğan · 2026

Read The CALLY Index Is Associated with Overall Survival in Patients with De Novo Metastatic Gastric Adenocarcinoma by Fahri Akgül, Süleyman Can, İvo Gökmen, Gizem Bakır Kahveci, İsmail Bayrakçı, Dicle Yurdatap Koç, Ece Demirdelen, Veli Çakıcı, Bülent Erdoğan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13304105.txt.

Description

Fahri Akgül and co-authors test, in a 2026 multicentre study, a combined blood index as a survival marker in stomach cancer that has already spread at diagnosis. The CALLY index blends an inflammation protein, a nutrition protein, and immune cell counts into one number. Its value in this specific, poor-prognosis group was undefined.

The study covered 234 patients treated between 2015 and 2025, split at a data-derived threshold into low and high index groups. Patients with high scores lived a median of nearly fourteen months against under nine months for the low group. The disadvantage of a low score persisted after adjustment for tumour features, treatment type, and diagnosis era. Time to progression, by contrast, showed no significant split.

Catalog record

CREATORFahri Akgül, Süleyman Can, İvo Gökmen, Gizem Bakır Kahveci, İsmail Bayrakçı, Dicle Yurdatap Koç, Ece Demirdelen, Veli Çakıcı, Bülent Erdoğan
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE25 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13304105

Browse the full library · About the Tower of Babel